#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Astrocytoma malignant Proteus syndrome Severe myoclonic epilepsy of infancy Stiff person syndrome Fusarium infection Polyneuropathy Hereditary ataxia Plasma cell myeloma Congenital cystic kidney disease Mixed-type liposarcoma Mantle cell lymphoma stage IV Bronchiolitis Leukocyte adhesion deficiency Methylmalonic acidaemia Malignant melanoma More trials…

    Learn about Rare Diseases

    Familial amyotrophic lateral sclerosis – Life with Disease Mantle cell lymphoma – Trials in Disease Primary biliary cholangitis – Basic Information Haemophilia B without inhibitors – Life with Disease Tuberous sclerosis complex – Life with Disease Uterine leiomyosarcoma – Basic Information Turner’s syndrome Breast angiosarcoma Lysosomal storage disorder – Trials in Disease Mastocytosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    D,L-Lysine Acetylsalicylate OLVEREMBATINIB Bjt-778 Ucp2 Patritumab Deruxtecan Birtamimab Entecavir Ads-015 Lixudebart Dolutegravir Famotidine POTASSIUM CLAVULANATE Lisdexamfetamine Dimesylate Munc-T3 Flutemetamol (18F) Satralizumab Ripasudil Boserolimab Cobamamide Apocynin More therapies…

    Learn about Your Condition

    Affective disorder Diabetic ketoacidosis Menopausal symptoms Uveitis Acquired ATTR amyloidosis Breast cancer female Thymic carcinoma Extra-osseous Ewing's sarcoma Essential hypertension Eye inflammation Malignant melanoma stage II Polymyalgia rheumatica Cervix carcinoma stage II Primary hypercholesterolaemia Hepatitis alcoholic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Dostarlimab for Patients with Untreated Locally Advanced Rectal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Dostarlimab
    France Germany Italy The Netherlands Spain

  • Study of Axitinib and Nivolumab for Patients with Metastatic Renal Cell Carcinoma Not Responding Completely to Initial Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastatic renal cell carcinoma
    Investigated Drugs:
    • Axitinib
    Italy Spain

  • Study Comparing PENG Block and Lumbar Plexus Block for Pain Relief and Mobility After Hip Replacement Using Levobupivacaine and Sodium Chloride in Hip Surgery Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hip arthroplasty
    Investigated Drugs:
    • Levobupivacaine
    • Sodium Chloride
    Spain

  • Study on Human Cancellous Bone for Partial Meniscal Replacement in Patients with Incomplete Meniscal Loss

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Meniscus injury
    • Meniscus operation
    Investigated Drugs:
    • Human Cancellous Bone
    Germany

  • Study on Azacitidine for Patients with Myelodysplastic Syndrome After Stem Cell Transplantation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Azacitidine
    Denmark Finland Norway Sweden

  • Study on How Tacrolimus Monohydrate and Mycophenolate Mofetil Affect Gut Bacteria in Patients with Chronic Kidney Disease After Transplant

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    • Renal transplant
    Investigated Drugs:
    • Tacrolimus Monohydrate
    • Mycophenolate Mofetil
    Belgium
Previous Page
1 … 449 450 451 452 453 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!